Zobrazeno 1 - 10
of 12
pro vyhledávání: '"irinorecan"'
Publikováno v:
OncoTargets and Therapy, Vol 2016, Iss Issue 1, Pp 1921-1926 (2016)
Gokmen Aktas,1 Tulay Kus,1 Mehmet Emin Kalender,1 Alper Sevinc,1 Celaletdin Camci,1 Seval Kul2 1Division of Medical Oncology, Department of Internal Medicine, School of Medicine, Gaziantep Oncology Hospital, Gaziantep University, Gaziantep, Turkey; 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::96e37444e63e460c8884c6b7b5c768f4
https://www.dovepress.com/survival-analysis-in-second-line-and-third-line-chemotherapy-with-irin-peer-reviewed-article-OTT
https://www.dovepress.com/survival-analysis-in-second-line-and-third-line-chemotherapy-with-irin-peer-reviewed-article-OTT
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dunn, Catherine, Wei Hong, Gibbs, Peter, Ackland, Stephen, Sjoquist, Katrin, Tebbutt, Niall C., Price, Timothy, Burge, Matthew, Hong, Wei
Publikováno v:
Clinical Colorectal Cancer; Sep2021, Vol. 20 Issue 3, p245-255, 11p
Autor:
Samalin, Emmanuelle, de la Fouchardière, Christelle, Thézenas, Simon, Boige, Valérie, Senellart, Hélène, Guimbaud, Rosine, Taïeb, Julien, François, Eric, Galais, Marie-Pierre, Lièvre, Astrid, Seitz, Jean-François, Metges, Jean-Philippe, Bouché, Olivier, Boissière-Michot, Florence, Lopez-Crapez, Evelyne, Bibeau, Frédéric, Ho-Pun-Cheung, Alexandre, Ychou, Marc, Adenis, Antoine, Di Fiore, Frédéric
Publikováno v:
Clinical Colorectal Cancer; Dec2020, Vol. 19 Issue 4, p301-310, 10p
Autor:
Lapeyre-Prost, Alexandra, Pernot, Simon, Sigrand, Julie, Le Malicot, Karine, Mary, Florence, Aparicio, Thomas, Dahan, Laetitia, Caroli-Bosc, Frangois-Xavier, Lecomte, Thierry, Doat, Solène, Marthey, Lysianne, Desrame, Jérôme, Lepage, Come, Taieb, Julien, Caroli-Bosc, François-Xavier
Publikováno v:
Clinical Colorectal Cancer; Dec2020, Vol. 19 Issue 4, p285-290, 6p
Autor:
A Jácome, Alexandre, Kee, Bryan, Fogelman, David, Dasari, Arvind, Shureiqi, Imad, Raghav, Kanwal, Morris, Van, Johnson, Benny, Overman, Michael, Wolff, Robert, Kopetz, Scott, Rogers, Jane, U Ahmed, Shahab, Mehdizadeh, Amir, Rothschild, Nicole, Eng, Cathy, Jácome, Alexandre A, Ahmed, Shahab U
Publikováno v:
Clinical Colorectal Cancer; Dec2020, Vol. 19 Issue 4, p248-255, 8p
Autor:
Park, Tae‐Hong, Eyster, Thomas W., Lumley, Joshua M., Hwang, Sangyeul, Lee, Kyung Jin, Misra, Asish, Rahmani, Sahar, Lahann, Joerg
Publikováno v:
Small; 9/23/2013, Vol. 9 Issue 18, p3051-3057, 7p
Autor:
Jean-Christophe, Boyer, Marie-Christine, Etienne-Grimaldi, Fabienne, Thomas, Sylvie, Quaranta, Nicolas, Picard, Marie-Anne, Loriot, Delphine, Poncet, Marie-Claude, Gagnieu, Cécile, Ged, Franck, Broly, Valérie, Le Morvan, Régis, Bouquié, Marie-Pierre, Gaub, Laurent, Philibert, François, Ghiringhelli, Chantal, Le Guellec
Publikováno v:
Bulletin du cancer. 101(6)
Irinotecan is a cytotoxic agent administered by IV infusion in the treatment of advanced colorectal cancer. Its anticancer activity results from its bioactivation into SN-38 metabolite, which is cleared through glucuronidation by the hepatic enzyme u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8faf035271776194b1e2f393e993e5b3
https://pubmed.ncbi.nlm.nih.gov/25817555
https://pubmed.ncbi.nlm.nih.gov/25817555
Publikováno v:
Bulletin du cancer.
Irinotecan (CPT11), a topoisomerase I inhibitor, is a new cytotoxic agent with a broad spectrum of clinical activity. Two main schedules have been studied and produce similar activity and side-effects: the "european" one--350 mg/m2 every 21 days-, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::504a7776952aba2009a73ea6adb3b863
https://pubmed.ncbi.nlm.nih.gov/9932080
https://pubmed.ncbi.nlm.nih.gov/9932080